Type of Practice: Internal Medicine, Cardiovascular Disease, Advanced Lipidology
Education/Professional Associations:
  • Fellowship, Cardiovascular Disease: Oakland University William Beaumont School of Medicine) Royal Oak, MI (1997)

  • Chief Cardiovascular Fellow: Oakland University William Beaumont School of Medicine, Royal Oak, MI (1996-1997)

  • Graduate: Master of Public Health/General Epidemiology, University of Michigan School of Public Health (1994)

  • Internship/Residency, Internal Medicine:  University of Washington School of Medicine, Seattle, WA (1991)

  • Medical School, MD Degree: University of Texas Southwestern Medical School, Dallas, TX (1988)

  • Undergraduate (honors): Bachelor of Science: Biology and Psychology, Baylor University, Waco, TX (1984)

Professional Affiliations:

  • Alpha Omega Alpha, National Honor Medical Society (1988-present)

  • American Heart Association, Council on Epidemiology and Prevention (1995-present)

  • American College of Cardiology (1997 to present)

  • Association of American Physicians and Surgeons (2020 to present)

  • Cardiorenal Society of America
    Founding Executive Board Member (2013-present); Vice President (2014-2016); President (2016-present)


Dr. Peter McCullough is board certified in internal medicine, cardiovascular diseases, and clinical lipidology. He completed his medical degree as an Alpha Omega Alpha graduate from the University of Texas Southwestern Medical School. Dr. McCullough went on to complete his internal medicine residency at the University of Washington, cardiology fellowship including service as Chief Fellow at William Beaumont Hospital, and master’s degree in public health at the University of Michigan.

Dr. McCullough is a founder and current president of the Cardiorenal Society of America. He has published in top-tier international journals, including the New England Journal of Medicine, Journal of the American Medical Association, Lancet, and British Medical Journal.  He is the editor-in-chief of Reviews in Cardiovascular Medicine and senior associate editor of the American Journal of Cardiology.  He also serves on the editorial boards of multiple specialty journals.

Dr. McCullough has been a leader in the medical response to the COVID-19 pandemic, contributing more than 45 peer-reviewed publications to date. He academic and clinical efforts in combating the SARS-CoV-2 virus have lead him to review thousands of reports, participate in scientific congresses, group discussions, and press releases.


Presentation Abstract

COVID-19 Vaccine Safety: Focus on Vaccine-Induced Myocarditis

The mRNA and adenoviral DNA vaccines have resulted in record numbers of vaccine injury reports and confirmed cases of both fatal and nonfatal syndromes. There are now >1000 peer reviewed and preprint papers describing COVID-19 vaccine injury syndromes. Most of these fall into one of four organ system categories: neurological, cardiovascular, immunologic, and hematologic. The US FDA has product warnings for Pfizer and Moderna mRNA vaccines for myocarditis or heart inflammation and autopsy confirmed fatal cases have been published. The FDA and foreign regulators have warnings for neurological thrombosis and Guillain-Barre syndrome for the adenoviral vector vaccines (Janssen and AstraZeneca). There are no prospective studies concerning screening, diagnosis, prognosis, or treatment of COVID-19 vaccine injury syndromes. As more cases accumulate with booster programs, there is a great need for research and clinical care for those who have been negatively impacted from indiscriminate COVID-19 vaccination.


Dr. McCullough has over 1,000 publications and 600 citations in the National Library of Medicine, on a broad range of topics. A partial list of his publications can be found on ResearchGate